2.1 – Changes in scope of consolidation

In 2014, the scope of consolidation for the Consolidated Financial Statements encompassed 281 companies (2013: 309). Of this number, four companies were first-time consolidations (2013: nine). Since the beginning of 2014, a total of 32 companies (2013: twelve) were deconsolidated due to divestiture, merger, liquidation or immateriality.

First-time consolidations in 2014 comprised:

  • Two newly established companies with headquarters in Germany and China
  • Two additional companies which had previously not been consolidated, headquartered in Germany and Peru

First-time consolidations in 2013 comprised:

  • A total of three companies in conjunction with the acquisition of Pronova BioPharma ASA
  • One company through the acquisition of Verenium Corporation
  • An additional five companies which had previously not been consolidated, headquartered in Germany, South Africa, Uruguay, Canada and China

A list of companies included in the Consolidated Financial Statements and a list of all companies in which BASF SE has a shareholding as required by Section 313(2) of the German Commercial Code is provided in the List of Shares Held.

Scope of consolidation

 

 

Europe

Thereof Germany

North America

Asia Pacific

South America, Africa, Middle East

2014

2013

As of January 1

 

189

67

42

55

23

309

312

Thereof proportionally consolidated

 

6

2

8

8

First-time consolidations

 

2

2

1

1

4

9

Thereof proportionally consolidated

 

Deconsolidations

 

27

4

3

2

32

12

Thereof proportionally consolidated

 

1

1

As of December 31

 

164

65

39

54

24

281

309

Thereof proportionally consolidated

 

6

1

7

8

Overview of impact of changes to the scope of consolidation (excluding acquisitions and divestitures)

 

 

2014

2013

 

 

Million €

%

Million €

%

Sales

 

15

0.0

32

0.0

 

 

 

 

 

 

Noncurrent assets

 

3

0.0

(3)

0.0

Thereof property, plant and equipment

 

3

0.0

1

0.0

Current assets

 

16

0.1

28

0.1

Thereof cash and cash equivalents

 

(3)

(0.2)

2

0.1

Assets

 

19

0.0

25

0.0

 

 

 

 

 

 

Equity

 

8

0.0

8

0.0

Noncurrent liabilities

 

0

0.0

5

0.0

Thereof financial indebtedness

 

0

0.0

0

0.0

Current liabilities

 

11

0.1

12

0.0

Thereof financial indebtedness

 

9

0.3

5

0.2

Total equity and liabilities

 

19

0.0

25

0.0

Contingent liabilities and other financial obligations

 

7

0.1

0

0.0